http://purl.uniprot.org/citations/34134925 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/34134925 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundThe cell surface interleukin 22 (IL-22) receptor complex is mainly expressed in epithelial and tissue cells like pancreatitis cells. Recent studies described that IL-22R was overexpressed in malignant diseases and was associated with a poor overall survival (OS). The role of IL-22RA1 gene expression in muscle invasive bladder cancer (MIBC) has not been investigated, yet.ObjectivesThe aim of this study was to analyze the role of IL-22RA1 gene expression in patients with MIBC.MethodsIn a cohort of 114 patients with MIBC who underwent radical cystectomy, IL-22RA1 gene expression was analyzed with qRT-PCR and correlated with clinical parameters. Furthermore, Kaplan-Meier and Cox regression analysis were performed. For validation, an in silico dataset (TCGA 2017, n=407) was reanalyzed.ResultsIL-22RA1 gene expression was independent of clinicopathological parameters like age (P=0.2681), T stage (P=0.2130), nodal status (P=0.3238) and lymph vascular invasion (LVI, P=0.5860) in patients with MIBC. A high expression of IL-22RA1 was associated with a shorter OS (P=0.0040) and disease-specific survival (P=0.0385). Furthermore, a shorter disease-free survival (DFS) was also associated with a high expression of IL-22RA1 (P=0.0102). In the multivariable analysis, IL-22RA1 expression was an independent prognostic predictors regarding OS (P=0.0096, HR=0.48). In the TCGA cohort, IL-22RA1 expression was independent regarding to OS and DFS.ConclusionA high IL-22RA1 gene expression was associated with worse outcome. Furthermore, IL-22RA1 represented an independent predictor regarding OS in our cohort and therefore might be used for risk stratification in patients with MIBC."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.org/dc/terms/identifier | "doi:10.1016/j.urolonc.2021.05.010"xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Porubsky S."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Neuberger M."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Nitschke K."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Erben P."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Weis C.A."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Gaiser T."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Nuhn P."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Weidenbusch M."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Worst T.S."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "von Hardenberg J."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Thaqi B."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Kriegmair M."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "Wessels F."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/author | "von Rhade S.M."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/date | "2021"xsd:gYear |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/name | "Urol Oncol"xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/pages | "499.e1-499.e8"xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/title | "High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer."xsd:string |
http://purl.uniprot.org/citations/34134925 | http://purl.uniprot.org/core/volume | "39"xsd:string |
http://purl.uniprot.org/citations/34134925 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/34134925 |
http://purl.uniprot.org/citations/34134925 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/34134925 |
http://purl.uniprot.org/uniprot/#_B4E2V9-mappedCitation-34134925 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34134925 |